BlackRock Inc. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 38 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$9,153,200
+9.8%
4,900,000
-2.0%
0.00%
Q3 2022$8,333,000
+23.8%
5,000,000
-7.0%
0.00%
Q2 2022$6,732,000
-26.1%
5,375,000
-22.7%
0.00%
Q1 2022$9,113,000
+59.5%
6,950,000
+78.2%
0.00%
Q4 2021$5,712,000
+38.7%
3,900,000
+24.8%
0.00%
Q2 2021$4,119,000
-5.9%
3,125,000
-6.7%
0.00%
Q1 2021$4,376,000
-37.4%
3,350,000
+17.5%
0.00%
Q4 2020$6,988,000
+43.4%
2,850,000
+21.3%
0.00%
Q3 2020$4,873,000
-9.6%
2,350,0000.0%0.00%
Q2 2020$5,393,000
+92.1%
2,350,000
+27.0%
0.00%
Q1 2020$2,808,000
-0.4%
1,850,000
+27.6%
0.00%
Q4 2019$2,820,000
+47.2%
1,450,0000.0%0.00%
Q3 2019$1,916,000
-40.6%
1,450,0000.0%0.00%
Q2 2019$3,228,000
+23.4%
1,450,0000.0%0.00%
Q1 2019$2,616,0001,450,0000.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 53,865,000$101,127,2803.93%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 88,657,000$165,397,6133.42%
Boussard & Gavaudan Investment Management LLP 11,898$21,871,5382.42%
TENOR CAPITAL MANAGEMENT Co., L.P. 38,394,000$71,834,2261.71%
WOLVERINE ASSET MANAGEMENT LLC 79,876,000$149,367,3841.55%
CSS LLC/IL 4,747,000$8,868,6060.50%
Opti Capital Management, LP 3,000,000$5,611,9380.48%
Verition Fund Management LLC 16,459,000$30,786,5600.48%
Aequim Alternative Investments LP 5,000,000$9,352,5000.25%
MIZUHO SECURITIES USA LLC 1,097,000$2,047,6160.19%
View complete list of SAREPTA THERAPEUTICS INC shareholders